Show simple item record

dc.contributor.authorGoubran, Hadi A.
dc.contributor.authorSholkamy, Sherif
dc.contributor.authorEl-Haddad, Alaa
dc.contributor.authorMahmoud, Alaa
dc.contributor.authorRizkallah, Mounir A.
dc.contributor.authorSobhy, George
dc.date2022-08-11T08:08:08.000
dc.date.accessioned2022-08-23T15:43:31Z
dc.date.available2022-08-23T15:43:31Z
dc.date.issued2012-09-05
dc.date.submitted2014-12-12
dc.identifier.citationThromb J. 2012 Sep 5;10(1):20. doi: 10.1186/1477-9560-10-20. <a href="http://dx.doi.org/10.1186/1477-9560-10-20">Link to article on publisher's site</a>
dc.identifier.issn1477-9560 (Linking)
dc.identifier.doi10.1186/1477-9560-10-20
dc.identifier.pmid22950681
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27113
dc.description.abstractBACKGROUND: Venous thromboembolism (VTE) is a leading cause of hospital-related deaths worldwide. However, the proportion of patients at risk of VTE who receive appropriate prophylaxis in Egypt is unknown. The ENDORSE study in Egypt is part of a global initiative to uncover the incidence of high-risk surgical and medical patients and determine what proportion of these patients receive appropriate VTE prophylaxis. METHODS: Ten Egyptian hospitals participated in this observational study, enrolling all surgical and medical patients that met the study criteria. This resulted in a cohort of 1,008 patients in acute care facilities who underwent a retrospective chart review. Each patient's VTE risk status and the presence or absence of appropriate prophylactic care was assessed according to the American College of Chest Physicians (ACCP) guidelines 2004. RESULTS: Of the 1,008 patients enrolled, 395 (39.2%) were found to be at high-risk for VTE. Overall, 227 surgical patients were at high-risk, although only 80 (35.2%) received ACCP-recommended prophylaxis. Similarly, 55/268 (32.75%) of high-risk medical patients received appropriate VTE prophylaxis. Low molecular weight heparin was the most commonly used anticoagulant, while mechanical prophylactic use was quite low (1.5%) in high-risk patients. CONCLUSIONS: In Egypt, more than one-third of all patients hospitalized for surgery or acute medical conditions are at high risk for developing VTE. However, only a small fraction of these patients receive appropriate VTE prophylaxis. Corrective measures are necessary for preventing VTE morbidity and mortality in these high risk patients.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22950681&dopt=Abstract">Link to Article in PubMed</a>
dc.rights<p>© 2012 Goubran et al.; licensee BioMed Central Ltd.</p> <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
dc.subjectVenous thromboembolism
dc.subjectEgypt
dc.subjectThromboprophylaxis
dc.subjectRisk factors
dc.subjectCardiovascular Diseases
dc.subjectClinical Epidemiology
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleVenous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
dc.typeJournal Article
dc.source.journaltitleThrombosis journal
dc.source.volume10
dc.source.issue1
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1013&amp;context=cor_endorse&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cor_endorse/14
dc.identifier.contextkey6456542
refterms.dateFOA2022-08-23T15:43:31Z
html.description.abstract<p>BACKGROUND: Venous thromboembolism (VTE) is a leading cause of hospital-related deaths worldwide. However, the proportion of patients at risk of VTE who receive appropriate prophylaxis in Egypt is unknown. The ENDORSE study in Egypt is part of a global initiative to uncover the incidence of high-risk surgical and medical patients and determine what proportion of these patients receive appropriate VTE prophylaxis.</p> <p>METHODS: Ten Egyptian hospitals participated in this observational study, enrolling all surgical and medical patients that met the study criteria. This resulted in a cohort of 1,008 patients in acute care facilities who underwent a retrospective chart review. Each patient's VTE risk status and the presence or absence of appropriate prophylactic care was assessed according to the American College of Chest Physicians (ACCP) guidelines 2004.</p> <p>RESULTS: Of the 1,008 patients enrolled, 395 (39.2%) were found to be at high-risk for VTE. Overall, 227 surgical patients were at high-risk, although only 80 (35.2%) received ACCP-recommended prophylaxis. Similarly, 55/268 (32.75%) of high-risk medical patients received appropriate VTE prophylaxis. Low molecular weight heparin was the most commonly used anticoagulant, while mechanical prophylactic use was quite low (1.5%) in high-risk patients.</p> <p>CONCLUSIONS: In Egypt, more than one-third of all patients hospitalized for surgery or acute medical conditions are at high risk for developing VTE. However, only a small fraction of these patients receive appropriate VTE prophylaxis. Corrective measures are necessary for preventing VTE morbidity and mortality in these high risk patients.</p>
dc.identifier.submissionpathcor_endorse/14
dc.contributor.departmentCenter for Outcomes Research
dc.source.pages20


Files in this item

Thumbnail
Name:
2012_10_1__20.pdf
Size:
270.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record